Citation Impact
4 by Nobel laureates 8 from Science/Nature 57 standout
Citing Papers
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Standout
Alzheimer's disease: From immunotherapy to immunoprevention
2023 Standout
Works of Thomas Dumortier being referenced
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
2012
O2‐05‐05: Results of the first‐in‐man study with the active Aβ Immunotherapy CAD106 in Alzheimer patients
2009
Author Peers
| Author | Surgery | CCM | Transplantation | Physiology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Thomas Dumortier | 32 | 98 | 38 | 227 | 119 | 21 | 567 | |
| André Luís Callegari | 10 | 5 | ||||||
| Zhong‐ning Zhu | 83 | 61 | 2 | 40 | 160 | 14 | 510 | |
| Neng-Ping Wang | 9 | 37 | 396 | |||||
| Xinlu Zhao | 11 | 1 | 2 | 57 | 15 | 440 | ||
| Metehan Irak | 2 | 3 | 2 | 1 | 25 | 253 |
All Works
Login with ORCID to disown or claim papers
Loading papers...